Skip to main content
Top

Current Gastroenterology Reports

Issue 6/2008

Content (16 Articles)

Invited Commentary

From bugs to drugs—Mining the gut microbiota

Fergus Shanahan

Clinical Trials Report

Is surveillance upper endoscopy indicated for gastric ulcers?

Joseph R. Pisegna

Pharmacology of proton pump inhibitors

Jai Moo Shin, George Sachs

Gastroduodenal mucosal defense

Amy Zhu, Jonathan Kaunitz

Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib

Philippe A. Cassier, Armelle Dufresne, Samia Arifi, Hiba El Sayadi, Isabelle Ray-Coquard, Pierre-Paul Bringuier, Jean-Yves Scoazec, Laurent Alberti, Jean-Yves Blay

Clinical Trials Report

Biologic therapy for inflammatory bowel disease comes of age

Stephen B. Hanauer

Recent advances in IBD pathogenesis: Genetics and immunobiology

David Q. Shih, Stephan R. Targan, Dermot McGovern

Optimizing treatment of inflammatory bowel diseases with biologic agents

Gert Van Assche, Séverine Vermeire, Paul Rutgeerts

Extraintestinal manifestations of inflammatory bowel disease

Horace Williams, David Walker, Timothy R. Orchard

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine